The LINCE Project: A Pathway for Diagnosing NCL2 Disease
IntroductionNeuronal Ceroid Lipofuscinosis (NCL) comprises a clinically and genetically heterogeneous group of 13 neurodegenerative lysosomal storage disorders. Neuronal Ceroid lipofuscinosis type 2 disease (NCL2), caused by the deficient lysosomal enzyme tripeptidyl peptidase 1 (TPP1), is the only...
Main Authors: | Daniel Rodrigues, Maria José de Castro, Pablo Crujeiras, Anna Duat-Rodriguez, Ana Victoria Marco, Mireia del Toro, María L. Couce, Cristóbal Colón |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-03-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2022.876688/full |
Similar Items
-
A tripeptidyl peptidase 1 is a binding partner of the Golgi pH regulator (GPHR) in Dictyostelium
by: Maria Stumpf, et al.
Published: (2017-07-01) -
Asynchronous Register Less NULL Convention Logic (RL-NCL) Pipeline Architectures Using Basic Gates
by: Gabriel C. Duarte, et al.
Published: (2022-12-01) -
In Vitro Activity of Robenidine Analogues NCL259 and NCL265 against Gram-Negative Pathogens
by: Hongfei Pi, et al.
Published: (2022-09-01) -
LINC01296 promotes neuroblastoma tumorigenesis via the NCL-SOX11 regulatory complex
by: Jing Wang, et al.
Published: (2022-03-01) -
Partial genetic suppression of a loss-of-function mutant of the neuronal ceroid lipofuscinosis-associated protease TPP1 in Dictyostelium discoideum
by: Jonathan E. Phillips, et al.
Published: (2015-02-01)